PriceTargets.com logo

Cue Health - HLTH Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.04 As of 06/6/2024 12:59 AM ET
▼ -0.0184 (-29.77%)
Get New Cue Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLTH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLTH

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Cue Health in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.04.

This chart shows the closing price for HLTH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Cue Health. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/14/2024BTIG ResearchReiterated RatingBuy ➝ Neutral
6/2/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral
5/15/2023BTIG ResearchLower Target$5.00 ➝ $3.00
11/15/2022BTIG ResearchLower Target$7.00
11/14/2022CowenLower TargetOutperform$9.00 ➝ $7.00
11/14/2022CowenLower TargetOutperform$9.00 ➝ $7.00
10/21/2022The Goldman Sachs GroupLower TargetBuy$7.00 ➝ $6.00
8/15/2022CowenLower Target$9.00
8/15/2022BTIG ResearchLower Target$9.00
8/11/2022Morgan StanleyLower TargetEqual Weight$10.00 ➝ $8.00
(Data available from 10/30/2019 forward)

News Sentiment Rating

0.75 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
6/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Cue Health logo
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.04
Low: $0.04
High: $0.06

50 Day Range

MA: $0.07
Low: $0.04
High: $0.13

52 Week Range

Now: $0.04
Low: $0.04
High: $0.74

Volume

96,004,600 shs

Average Volume

13,378,568 shs

Market Capitalization

$6.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Cue Health?

The following equities research analysts have issued research reports on Cue Health in the last year: BTIG Research.
View the latest analyst ratings for HLTH.

What is the current price target for Cue Health?

0 Wall Street analysts have set twelve-month price targets for Cue Health in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Cue Health in the next year.
View the latest price targets for HLTH.

What is the current consensus analyst rating for Cue Health?

Cue Health currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HLTH, but not buy more shares or sell existing shares.
View the latest ratings for HLTH.

What other companies compete with Cue Health?

Other companies that are similar to Cue Health include Bionano Genomics, Astrotech, Precipio, Talis Biomedical and Telesis Bio. Learn More about companies similar to Cue Health.

How do I contact Cue Health's investor relations team?

Cue Health's physical mailing address is 4980 CARROLL CANYON ROAD SUITE 100, SAN DIEGO CA, 92121. The company's listed phone number is 858-412-8151 and its investor relations email address is [email protected]. The official website for Cue Health is www.cuehealth.com. Learn More about contacing Cue Health investor relations.